Toxicological assessment of cigarette ingredients

Regulatory Toxicology and Pharmacology

Volumn 61, Issue 1, 2011, Pages 119-128

  Dempsey, Ruth ^a   Coggins, Christopher R E ^b   Roemer, Ewald ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Carson Watts Consulting   (United States)

Author keywords

Additive; Cigarette smoke; Ingredient; Testing; Toxicity

Indexed keywords

ARTICLE; CARCINOGENICITY; CARDIOTOXICITY; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CYTOTOXICITY TEST; GENOTOXICITY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MUTAGENICITY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; TOBACCO; TOXICITY TESTING;

ENZYME INHIBITORS; GUIDELINES AS TOPIC; HUMANS; SMOKE; SMOKING; TARS; TOBACCO; TOBACCO INDUSTRY;

NICOTIANA TABACUM;

EID: 80052416530     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2011.07.002     Document Type: Article

References (86)

1. Andreoli C., et al. A review of in vitro methods to assess the biological activity of tobacco smoke with the aim of reducing the toxicity of smoke. Toxicol. In Vitro 2003, 17:587-594.
2. Baker R.R. Smoke chemistry. Tobacco: Production, Chemistry, and Technology 1999, 398-439. Blackwell Science, Oxford. D.L. Davis, M.T. Nielsen (Eds.).
3. Baker R.R., Bishop L.J. The pyrolysis of tobacco ingredients. J. Anal. Appl. Pyrol. 2004, 71:223-311.
4. Baker R.R., et al. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 2004, 42S:S53-S83.
5. Benigni R., et al. Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays. Exp. Opin. Drug. Metab. Toxicol. 2010, 6:809-819.
6. Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 1: cigarette design, testing approach, and review of results. Food Chem. Toxicol 2002, 40:77-91.
7. Carmines E.L., Gaworski C.L. Toxicological evaluation of glycerin as a cigarette ingredient. Food Chem. Toxicol. 2005, 43:1521-1539.
8. Carmines E.L., et al. Toxicologic evaluation of licorice extract as a cigarette ingredient. Food Chem. Toxicol. 2005, 43:1303-1322.
9. Coggins C.R.E. A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice. Inhal. Toxicol. 2010, 22:974-983.
10. Coggins C.R.E., et al. The tumourigenicity of smoke condensates from cigarettes containing different amounts of Cytrel, as assessed by mouse skin painting. Toxicology 1982, 23:177-185.
11. Coggins C.R.E., et al. Chronic inhalation study in rats, using cigarettes containing different amounts of Cytrel tobacco supplement. Toxicology 1982, 22:287-296.
12. Coggins C.R.E., et al. Comparative inhalation study in rats using cigarettes containing tobacco expanded with chlorofluorocarbon-11 (CFC-11) or hydrochlorofluorocarbon-123 (HCFC-123). Inhal. Toxicol. 1992, 5:97-115.
13. COT COC COM, Joint statement on the re-assessment of the toxicological testing of tobacco products. Committees on toxicity, carcinogenicity, mutagenicity of chemicals in foods, consumer products and the environment, London, 2004.
14. COT COC COM, Committee on carcinogenicity. Carcinogenicity testing of tobacco products. Committees on toxicity, mutagenicity, carcinogenicity of chemicals in food, consumer products and the environment. Annual Report 2009, London, 2009.
15. DIN, Toxicological evaluation of additives for tobacco products - a guide. DIN Technical Report 133. Deutsches Institut fur Normung, Berlin, 2004.
16. European Commission, Reporting on tobacco product ingredients. PRACTICAL GUIDE. European Commission. Health & Consumer Protection Directorate-General. SANCO C6 TPE/ub (2007) 360206, Brussels, Belgium, 2007.
17. European Union, Directive 2001/37/EC of the European Parliament and of the council of 5 June 2001, on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products. Official Journal of the European Communities, L 194, 26-34, 2001.
18. FDA, US Congress. Family smoking prevention and tobacco control act. Section 911. Modified risk tobacco products., H.R. 1256, 2009.
19. Frost-Pineda K., et al. 12-Week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul. Toxicol. Pharmacol. 2008, 52:111-117.
20. Gaworski C.L., et al. 13-Week inhalation toxicity study of menthol cigarette smoke. Food Chem. Toxicol. 1997, 35:683-692.
21. Gaworski C.L., et al. Toxicologic evaluation of flavor ingredients added to cigarette tobacco: 13-week inhalation exposures in rats. Inhal. Toxicol. 1998, 10:357-381.
22. Gaworski C.L., et al. Toxicologic evaluation of flavor ingredients added to cigarette tobacco: skin painting bioassay of cigarette smoke condensate in SENCAR mice. Toxicology 1999, 139:1-17.
23. Gaworski C.L., et al. Toxicological evaluation of potassium sorbate added to cigarette tobacco. Food Chem. Toxicol. 2007, 46:339-351.
24. Gaworski C.L., et al. Palladium alters cigarette smoke toxicological profile, but accumulates in the lungs of rodents during inhalation exposure. Inhal. Toxicol. 2008, 20:167-182.
25. Gaworski C.L., et al. Toxicological considerations on the use of propylene glycol as a humectant in cigarettes. Toxicology 2010, 269:54-66.
26. German Cancer Research Center Increased Health Hazards Due to Additives of Tobacco Products - Consequences for Product Regulation 2005, German Cancer Research Center, Heidelberg. H.W. Thielmann, M. Pötschke-Langer (Eds.).
27. German Cancer Research Center Strategy for Toxicity Evaluation of Tobacco Additives and their Regulation 2010, German Cancer Research Center, Heidelberg. M. Schwenk (Ed.).
28. Gori G.B. Virtually safe cigarettes. Reviving an opportunity once tragically rejected 2000, IOS Press, Amsterdam.
29. Green J.D., et al. The transfer of tobacco additives to cigarette smoke. Examination of the possible contribution of pyrolysis products to mainstream smoke composition. Tabakforsch. Intl. 1989, 14:283-288.
30. Hahn J., Schaub J. Influence of tobacco additives on the chemical composition of mainstream smoke. Beitr. Tabakforsch. Intl. 2010, 24:100-116.
31. Heck J.D., et al. Toxicologic evaluation of humectants added to cigarette tobacco: 13-week smoke inhalation study of glycerin and propylene glycol in Fischer 344 rats. Inhal. Toxicol. 2002, 14:1135-1152.
32. Hoffmann D., et al. The changing cigarette. Prev. Med. 1997, 26:427-434.
33. Hoffmann D., et al. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 2001, 14:768-790.
34. ICH, Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals: S2A., International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. International Conference on Harmonisation., Geneva, Switzerland., 1995a.
35. ICH, Guideline on the need for carcinogenicity studies of pharmaceuticals: S1A., International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. International Conference on Harmonisation., Geneva, Switzerland., 1995b.
36. ICH, Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals: S2B., International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for clinical use. International Conference on Harmonisation, Geneva, Switzerland, 1997.
37. Independent Scientific Committee on Smoking and Health, Tobacco substitutes and additives in tobacco products. Department of Health and Social Security, HMSO, London, 1975.
38. Institute of Medicine Assessing the science base for tobacco harm reduction 2001, National Academy Press, Washington, DC 20055.
39. Kinsler S., et al. Rat subchronic inhalation study of smoke from cigarettes containing flue-cured tobacco cured either by direct-fired or heat-exchanger curing processes. Inhal. Toxicol. 2003, 15:819-854.
40. Kirkland D., et al. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat. Res. 2011, 721:27-73.
41. Kroes R., et al. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 2004, 42:65-83.
42. Lee P.N., et al. Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD?. Inhal. Toxicol. 2009, 21:404-430.
43. Lemus R., et al. Toxicological comparisons of cigarettes containing different amounts of vanillin. Inhal. Toxicol. 2007, 19:683-699.
44. Life Sciences Research Office Review of ingredients added to cigarettes. Phase one: the feasibility of testing ingredients added to cigarettes 2004, LSRO, Bethesda, MD.
45. Life Sciences Research Office Review of ingredients added to cigarettes. Phase two: scientific criteria for the evaluation of ingredients added to cigarettes 2004, LSRO, Bethesda, MD.
46. Life Sciences Research Office Biological effects assessment in the evaluation of potential reduced-risk products 2007, LSRO, Bethesda, MD.
47. Life Sciences Research Office Exposure assessment in the evaluation of potential reduced-risk tobacco products 2007, LSRO, Bethesda, MD.
48. Liu C. Glycerol transfer in cigarette mainstream smoke. Beitr. Tabakforsch. Intl. 2004, 21:111-116.
49. Munro I.C., et al. Thresholds of toxicological concern based on structure-activity relationships. Drug Metab. Rev. 1996, 28:209-217.
50. Munro I.C., et al. The Threshold of Toxicological Concern (TTC) in risk assessment. Toxicol. Lett. 2008, 180:151-156.
51. Paschke T., et al. Effects of ingredients on cigarette smoke composition and biological activity: a literature overview. Beitr. Tabakforsch. Intl. 2002, 20:107-247.
52. Potts R.J., et al. Comparative 13-week inhalation study of cigarette smoke from cigarettes containing cast sheet tobacco. Inhal. Toxicol. 2007, 19:701-724.
53. Renne R.A., et al. Effects of flavoring and casing ingredients on the toxicity of mainstream cigarette smoke in rats. Inhal. Toxicol. 2006, 18:685-706.
54. Rodgman A. Some studies on the effects of additives on cigarette mainstream smoke properties. I. Flavorants. Beitr. Tabakforsch. Intl. 2002, 20:83-103.
55. Rodgman A. Some studies on the effects of additives on cigarette mainstream smoke properties. II. Casing materials and humectants. Beitr. Tabakforsch. Intl. 2002, 20:279-299.
56. Rodgman A. Some studies on the effects of additives on cigarette mainstream smoke properties. III. Ingredients reportedly used in various commercial cigarette products in the USA and elsewhere. Beitr. Tabakforsch. Intl. 2004, 21:47-104.
57. Roemer E., Hackenberg U. Mouse skin bioassay of smoke condensates from cigarettes containing different levels of cocoa. Food Addit. Contam. 1990, 7:563-569.
58. Roemer E., et al. Evaluation of the potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food Chem. Toxicol. 2002, 40:105-111.
59. Roemer E., et al. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 2004, 195:31-52.
60. Roethig H.J., et al. Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. J. Clin. Pharmacol. 2005, 45:133-145.
61. Rogers M.D. Risk analysis under uncertainty, the precautionary principle, and the new EU chemicals strategy. Regul. Toxicol. Pharmacol. 2003, 37:370-381.
62. Rustemeier K., et al. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem. Toxicol. 2002, 40:93-104.
63. Schramke H., et al. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 2006, 227:193-210.
64. Scientific Committee on Tobacco and Health (SCOTH), Annex K. Voluntary agreement for the approval and use of new additives to tobacco products in the United Kingdom, 1997. Department of Health, London, 1998.
65. Smith R.L., et al. Criteria for the safety evaluation of flavoring substances. The Expert Panel of the Flavor and Extract Manufacturers Association. Food Chem. Toxicol. 2005, 43:1141-1177.
66. Stavanja M.S., et al. Toxicological evaluation of honey as an ingredient added to tobacco. J. Toxicol. Environ. Health. 2003, 66:1453-1473.
67. Stavanja M.S., et al. Safety assessment of high fructose corn syrup (HFCS) as an ingredient added to cigarette tobacco. Exp. Toxicol. Pathol. 2006, 57:267-281.
68. Stavanja M.S., et al. Safety assessment of diammonium phosphate and urea used in the manufacture of cigarettes. Exp.Toxicol. Pathol. 2008, 59:339-353.
69. Stotesbury S.J., et al. The pyrolysis of tobacco additives as a means of predicting their behaviour in a burning cigarette. Beitr. Tabakforsch. Intl. 1999, 18:147-163.
70. Stotesbury S.J., et al. Pyrolysis of cigarette ingredients labelled with stable isotopes. Beitr. Tabakforsch. Intl. 2000, 19:55-64.
71. Talhout R., et al. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 2011, 8:613-628.
72. Theophilus E.H., et al. Toxicological evaluation of propane expanded tobacco. Food Chem. Toxicol. 2003, 41:1771-1780.
73. Theophilus E.H., et al. Toxicologic evaluation of dry ice expanded tobacco. Toxicol. Lett. 2003, 145:107-119.
74. Theophilus E.H., et al. Toxicological evaluation of expanded shredded tobacco stems. Food Chem. Toxicol. 2004, 42:631-639.
75. Theophilus E.H., et al. Toxicological evaluation of cigarettes with two banded cigarette paper technologies. Exp.Toxicol. Pathol. 2007, 59:17-27.
76. Thielen A., et al. Tobacco smoke: unraveling a controversial subject. Exp.Toxicol. Pathol. 2008, 60:141-156.
77. Torikai K., et al. Effects of temperature, atmosphere and pH on the generation of smoke compounds during tobacco pyrolysis. Food Chem. Toxicol. 2004, 42:1409-1417.
78. Torikai K., et al. Study on tobacco components involved in the pyrolytic generation of selected smoke constituents. Food Chem. Toxicol. 2005, 43:559-568.
79. US Department of Health and Human Services, How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, 2010.
80. US Department of Health and Human Services, Guidance for Industry and FDA staff. Section 905(j) Reports: demonstrating Substantial Equivalence for Tobacco Products. Food and Drug Administration, Center for Tobacco Products. OMB Control Number 0910-0873, Rockville, MD, 2011.
81. Van Miert E., et al. Evaluation of the micronucleus assay in bone marrow and peripheral blood of rats for the determination of cigarette mainstream-smoke activity. Mutat. Res. 2008, 652:131-138.
82. Vanscheeuwijck P.M., et al. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem. Toxicol. 2002, 40:113-131.
83. Veltel D.J., Hoheneder A. Characterization of cigarette smoke-induced micronuclei in vitro. Exp. Toxicol. Pathol. 1996, 48:548-550.
84. Werley M.S., et al. Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul. Toxicol. Pharmacol. 2007, 47:189-203.
85. World Health Organization Tobacco: deadly in any form or disguise 2006, World Health Organization, Geneva.
86. World Health Organization, The scientific basis of tobacco product regulation. Second Report of a WHO study group. WHO Technical Report Series: No. 951. World Health Organization, Geneva, Switzerland, 2008.